Amra Remedies targets turnover of Rs 100 crore in FY 2012-13
Plans capex of Rs 40-45 crore
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
ACTA Down, but What Next?
The EU Parliament has rejected the Anti-Counterfeiting Trade Agreement (ACTA), but there are other similar moves to restrict free…
Thermo Fisher Scientific to buy One Lambda for $925 million
The transaction is expected to be completed in fourth quarter of 2012
BASF named world’s most transparent chemical company globally
Rating based on openness, transparency, and steps to fight corruption
Suven to present at Alzheimer’s Association International Conference
Data on pre clinical molecule to be presented at the Vancouver conference
Domestic pharma companies likely to see steady growth in Q1FY13: Analysts
Tax rates hikes and forex losses could however cloud the picture for certain companies
CritiTech signs joint ventute agreement with Finoso Pharma
To provide alternative API size reduction technology and particle design services to the pharmaceutical industry
Merck’s phase III trial for Odanacatib shows promising result
Study met its primary efficacy outcomes at first planned interim analysis and is being concluded early